Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
We compare Zero Based, envelope, and traditional budgeting methods, outlining strengths, tradeoffs, and scenarios where each excels.
19,513 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Midsize U.S. firms reduced payments to Chinese suppliers in 2025 as tariff policy remained volatile, signaling a broa...
Mortgage rates fall multiyear as bond markets stabilize and spreads tighten, signaling stronger spring demand for hom...
Tariffs and policy shifts can ripple through energy markets in surprising ways. This guide breaks down the three esse...
Florida enters its worst drought in a generation, worsening the squeeze on citrus farmers already dealing with diseas...
A global energy crunch tied to the Iran war is renewing talk of a permanent four-day workweek. Experts say the shift ...
Druski’s latest skit already exploded across social media, showing how fast virality can translate into income—if you...
Anthropic’s spacex compute deal expands access to the Colossus supercomputer, boosting Claude capacity while triggeri...
Anthropic's new findings on Claude's misalignment collide with Elon Musk's public remarks, as investors weigh AI narr...
Set up your weekend with a curated mix of Friday reads for investors. This guide rounds up 10 must-check pieces that ...
A public clash over strategy and governance wrapped up for now, but 2026 could be a real test for lululemon. This inv...
A legendary rock family grows again, and with that milestone comes practical money lessons. This article uses the mom...